Evidence map›Paper›PMID 36820317›Full record

ArticleOpen forum infectious diseases2023

A Predictive Model to Identify Complicated

Jeffrey A Berinstein, Calen A Steiner, Samara Rifkin, D Alexander Perry, Dejan Micic, Daniel Shirley, Peter D R Higgins, Vincent B Young, Allen Lee, Krishna Rao

Open access · goldAbstract read
In one paragraph

Article in Open forum infectious diseases, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.8field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 4 citations in OpenAlex.

  1. Review
  2. Defining FulminantOpen forum infectious diseases · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 1 country.

Jeffrey A BerinsteinDivision of Gastroenterology and Hepatology, University of Michigan, Ann Arbor, Michigan, USA.
Calen A SteinerDivision of Gastroenterology and Hepatology, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA.
Samara RifkinDivision of Gastroenterology and Hepatology, University of Michigan, Ann Arbor, Michigan, USA.
D Alexander PerryDivision of Infectious Diseases, University of Arizona, Tucson, Arizona, USA.
Dejan MicicSection of Gastroenterology, Hepatology, and Nutrition, University of Chicago, Chicago, Illinois, USA.
Daniel ShirleyDivision of Infectious Diseases, University of Wisconsin, Madison, Wisconsin, USA.
Peter D R HigginsDivision of Gastroenterology and Hepatology, University of Michigan, Ann Arbor, Michigan, USA.
Vincent B YoungDivision of Infectious Diseases, University of Michigan, Ann Arbor, Michigan, USA.
Allen LeeDivision of Gastroenterology and Hepatology, University of Michigan, Ann Arbor, Michigan, USA.ORCID https://orcid.org/0000-0002-4861-7646
Krishna RaoDivision of Infectious Diseases, University of Michigan, Ann Arbor, Michigan, USA.
University of Michigan · USUniversity of Arizona · USUniversity of Chicago · USUniversity of Colorado Anschutz Medical Campus · USUniversity of Wisconsin–Madison · US

Funding

A Systems Biology Approach Using Fecal Microbiota and Metabolomics to Identify Novel Subtypes in Irritable Bowel Syndrome.K23DK124567 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI LEE, ALLEN A · 2021 to 2023
$729k
NIDDK NIH HHS K23 DK124567
6 · The paper itself

Abstract

Background: Methods: We conducted a multicenter retrospective cohort study of adults diagnosed with CDI. After randomly partitioning the data into training and validation sets, we developed and compared 3 machine learning algorithms (lasso regression, random forest, stacked ensemble) with 10-fold cross-validation to predict disease-related complications (intensive care unit admission, colectomy, or death attributable to CDI) within 30 days of diagnosis. Model performance was assessed using the area under the receiver operating curve (AUC). Results: A total of 3646 patients with CDI were included, of whom 217 (6%) had complications. All 3 models performed well (AUC, 0.88-0.89). Variables of importance were similar across models, including albumin, bicarbonate, change in creatinine, non-CDI-related intensive care unit admission, and concomitant non-CDI antibiotics. Sensitivity analyses indicated that model performance was robust even when varying derivation cohort inclusion and CDI testing approach. However, race was an important modifier, with models showing worse performance in non-White patients. Conclusions: Using a large heterogeneous population of patients, we developed and validated a prediction model that estimates risk for complications from CDI with good accuracy. Future studies should aim to reduce the disparity in model accuracy between White and non-White patients and to improve performance overall.

Indexed as

Clostridiodes difficilemachine learningpredictive modelsevere disease

Identifiers

PMID36820317
PMCPMC9938520
OpenAlexW4319037880

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.